Adam Bevan
Neurological Surgery · Provo, UTNPI 1992110787
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,469 of the $5,254 with a category attached, or 66.0%. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 32.4% of the total.
Across 41 payments — averaging $128.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$2K
- Monteris Medical Corporation$1K
- Centinel Spine, LLC$1K
- Si-bone, Inc.$437
- Integra Lifesciences Corporation$149
- Boston Scientific$141
- plus $382 from 8 others
What the payments were for
- Travel & lodging$3,46966%
- Food & beverage$1,54429%
- Education$2405%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 10 | $1,702 |
| Monteris Medical Corporation | 7 | $1,227 |
| Centinel Spine, LLC | 4 | $1,215 |
| Si-bone, Inc. | 4 | $437 |
| Integra Lifesciences Corporation | 2 | $149 |
| Boston Scientific | 3 | $141 |
| Globus Medical | 2 | $137 |
| Relievant Medsystems, Inc. | 2 | $78 |
| Johnson & Johnson | 2 | $61 |
| Medtronic | 1 | $31 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Almatica Pharma LLC | 1 | $23 |
| Baxter Healthcare | 1 | $15 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPEDIUM$1,354
- PRODISC L$1,207
- Neuroblate$1,006
- IFUSE IMPLANT SYSTEM$328
- CODMAN CERTAS$132
- CUSA CLARITY$132
- DURAGEN DURAL GRAFT MATRIX$132
- DURASEAL EXACT SPINAL SEALANT SYSTEM$132
- HAKIM$132
- ALTERA$120
How this compares
$5,254 in reported general payments places this provider in the 60th percentile of 75 neurological surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 35 | $457 |
| Methocarbamol | 14 | $140 |
| Oxycodone Hcl | 21 | $100 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Provo
- Howard ReichmanProvo$451K
- Ian DorwardProvo$104K
- Mark MahanSalt Lake City$698K
- Ramesh GrandhiSalt Lake City$586K
- Marion WalkerSlc$381K
- Kenneth YonemuraSalt Lake City$117K
- Brian AndersonLehi$82K
- Andrew DaileySalt Lake City$74K
- Craig KilburgSalt Lake City$66K
- Ronald ApfelbaumSalt Lake City$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.